[
  {
    "ts": null,
    "headline": "Kenvue Stock Has Unusual Put Option Activity After Lower Q2 Sales and CEO Firing",
    "summary": "Kenvue, which manufactures Band-Aid, Listerine, Neutrogena, and Johnson's consumer products, reported disappointing Q2 sales and just announced that its CEO had left. Put options are showing unusually high volume today.",
    "url": "https://finnhub.io/api/news?id=2a23d2ea6e405aa3e311cdd484ba328d7c7d5179864e679796f0dce7c202c496",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752687002,
      "headline": "Kenvue Stock Has Unusual Put Option Activity After Lower Q2 Sales and CEO Firing",
      "id": 135994289,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "KVUE",
      "source": "Yahoo",
      "summary": "Kenvue, which manufactures Band-Aid, Listerine, Neutrogena, and Johnson's consumer products, reported disappointing Q2 sales and just announced that its CEO had left. Put options are showing unusually high volume today.",
      "url": "https://finnhub.io/api/news?id=2a23d2ea6e405aa3e311cdd484ba328d7c7d5179864e679796f0dce7c202c496"
    }
  },
  {
    "ts": null,
    "headline": "Kenvue Inc. stock rises Wednesday, outperforms market",
    "summary": "Kenvue Inc. stock rises Wednesday, outperforms market",
    "url": "https://finnhub.io/api/news?id=953c05b887581407539f30303781fcf152400bf113009d6bedbcc7d36dd67fb5",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752684720,
      "headline": "Kenvue Inc. stock rises Wednesday, outperforms market",
      "id": 135983553,
      "image": "",
      "related": "KVUE",
      "source": "MarketWatch",
      "summary": "Kenvue Inc. stock rises Wednesday, outperforms market",
      "url": "https://finnhub.io/api/news?id=953c05b887581407539f30303781fcf152400bf113009d6bedbcc7d36dd67fb5"
    }
  },
  {
    "ts": null,
    "headline": "JNJ Begins Drug Sector Q2 Earnings With a Beat & Guidance Raise",
    "summary": "JNJ tops second-quarter estimates and raises 2025 guidance as Innovative Medicines outperforms and MedTech gains momentum.",
    "url": "https://finnhub.io/api/news?id=b36b76f3318893985e41ba18ea1f8749ef4860c069925b859aa650f87d6bde9a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752677580,
      "headline": "JNJ Begins Drug Sector Q2 Earnings With a Beat & Guidance Raise",
      "id": 135994290,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "KVUE",
      "source": "Yahoo",
      "summary": "JNJ tops second-quarter estimates and raises 2025 guidance as Innovative Medicines outperforms and MedTech gains momentum.",
      "url": "https://finnhub.io/api/news?id=b36b76f3318893985e41ba18ea1f8749ef4860c069925b859aa650f87d6bde9a"
    }
  },
  {
    "ts": null,
    "headline": "Kenvue's Q2 2025 Earnings: What to Expect",
    "summary": "Kenvue is expected to release its second-quarter earnings next month, and analysts anticipate a double-digit profit dip.",
    "url": "https://finnhub.io/api/news?id=d1c25913344506bbe80143dea58e55c1d9940f13610e2e333f7017b775102522",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752665885,
      "headline": "Kenvue's Q2 2025 Earnings: What to Expect",
      "id": 135966101,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "KVUE",
      "source": "Yahoo",
      "summary": "Kenvue is expected to release its second-quarter earnings next month, and analysts anticipate a double-digit profit dip.",
      "url": "https://finnhub.io/api/news?id=d1c25913344506bbe80143dea58e55c1d9940f13610e2e333f7017b775102522"
    }
  }
]